ARTICLE | Emerging Company Profile
Immune orchestration
Alpine developing single-molecule alternative to immunotherapy combos
February 8, 2016 8:00 AM UTC
Alpine Immune Sciences Inc. is developing multispecific proteins to achieve the effects of immunotherapy combinations, but with more control and using a single molecule.
The company's vIgD platform is based upon endogenous proteins that exist within the synapse between an immune cell and its target cell. ...